跳至主要内容
临床试验/EUCTR2015-001923-22-NL
EUCTR2015-001923-22-NL进行中(未招募)1 期

The effect of adenosine on myocardial protection in intermittent warm blood cardioplegia: a randomized placebo-controlled trial

Amphia Ziekenhuis0 个研究点目标入组 100 人开始时间: 2015年11月19日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Gender; male/ female
  • Age: = 18 year
  • Elective cardiac surgical patients: - minimally invasive, port access surgery (mitral valve surgery)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • Patients who meet any of the following criteria will be excluded from participation in this study:
  • All non-minimally invasive surgery
  • Theophylline or dipyridamole use
  • Caffeine use up to 12 hours prior to surgery

研究者

发起方
Amphia Ziekenhuis

相似试验

Adenosine as an adjunct to standaard blood... | 临床试验